Profiel
Antonio Herce is an Investment Director at Inveready Asset Management SGEIC SA. He is also a Board Member at Bionanoplus SL, Atlas Molecular Pharma SL, and 3D-Shaper Medical.
Mr. Herce completed his undergraduate degree at the University of Lleida in 2015 and his graduate degree at the University of Barcelona in 2016.
Actieve functies van Antonio Herce
| Bedrijven | Functie | Begin |
|---|---|---|
Inveready Asset Management SGEIC SA
Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready invests in both public and private companies located in Europe and North America. The firm targets companies operating in the fields of infrastructure, life sciences and technology sectors. It provides debt and equity financing for buyouts, secondary, early and growth capital requirements with an investment size ranging between EUR 0.5 million and 5 million. | Private Equity Investor | 01-05-2023 |
Atlas Molecular Pharma SL
Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Directeur/Bestuurslid | 01-01-2022 |
3D-Shaper Medical | Directeur/Bestuurslid | 01-03-2021 |
Bionanoplus SL
Bionanoplus SL BiotechnologyHealth Technology Designs and develops drug delivery systems | Directeur/Bestuurslid | 01-12-2019 |
Opleiding van Antonio Herce
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of Barcelona
University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inveready Asset Management SGEIC SA
Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready invests in both public and private companies located in Europe and North America. The firm targets companies operating in the fields of infrastructure, life sciences and technology sectors. It provides debt and equity financing for buyouts, secondary, early and growth capital requirements with an investment size ranging between EUR 0.5 million and 5 million. | Finance |
University of Lleida
University of Lleida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionanoplus SL
Bionanoplus SL BiotechnologyHealth Technology Designs and develops drug delivery systems | Health Technology |
Atlas Molecular Pharma SL
Atlas Molecular Pharma SL Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of therapeutics for the treatment of patients suffering from rare diseases | Commercial Services |
3D-Shaper Medical |
















